Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

NCT04604002 is registered in ClinicalTrials.gov with Heidelberg Engineering GmbH as lead sponsor.

NCT NCT04604002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04604002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types
Lead sponsor
Heidelberg Engineering GmbH
Phase
Observational
Overall status
Completed
Start date
October 15, 2020
Completion date
January 4, 2022
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

normal eyes, retinal vascular